The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on Palladium
... Read more »
Often maligned biotech/life sciences hedge funds logged exceptional double digit returns in the last 12 months as other long/short equity managers struggled to even come close to the S&P 500’s 30% plus gains
... Read more »
While the hedge fund indices and inflow data tell us that this year was less than optimal for hedge funds, much can be learned about what the future for the industry holds by eyeing some of the main trends at the three largest global hedge fund firms – Bridgewater, Renaissance Technologies and AQR Capital Management
... Read more »
The following report is provided free each week by McAlinden Research Partners exclusively to members of Hedge Connection. Today’s issue cluster focuses on Emerging Markets
... Read more »
No one will argue that its been a tough year for hedge funds, with fund closures and even some legends in the industry underperforming the U.S equity stock market that continues to make records daily.
Should portfolio managers be partying like it’s 1999 or as though it is 2000 – which kicked off a decade of blockbuster returns and inflows?
